Biogen Inc. announced that the U.S. Food and Drug Administration (FDA) has accepted the company's supplemental New Drug Application (sNDA) and the European Medicines Agency (EMA) has validated the ...
SKWD's focus on high-return areas, prudent pricing, better retention and shifting of the business mix toward more profitable lines makes it poised for growth.
WisdomTree, Inc. (NYSE: WT), a global financial innovator, today announced that the Siegel-WisdomTree Moderate, Longevity and Global Equity Model Portfolios are now available on the UBS Financial ...